Science & Enterprise subscription

Follow us on Twitter

  • In one of its first actions, the Biden administration rejoined the United States in the World Health Organization,… https://t.co/gpHTTr70DP
    about 12 hours ago
  • New post on Science and Enterprise: U.S. Rejoins WHO, Participates in Int’l Vaccine Project https://t.co/bBUZr5UzSg #Science #Business
    about 12 hours ago
  • A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower ris… https://t.co/EPYrP8wElE
    about 16 hours ago
  • New post on Science and Enterprise: Antibodies Prevent Covid-19 Symptoms in Long-Term Care https://t.co/sePqojZMVd #Science #Business
    about 16 hours ago
  • Another way to connect 100 million people end-to-end with Covid-19 vaccines. https://t.co/wIWk0XNDhv
    about 1 day ago

Please share Science & Enterprise

Antibodies Prevent Covid-19 Symptoms in Long-Term Care

Mobile lab team

A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower risk of getting symptomatic Covid-19 infections. . . . → Read More: Antibodies Prevent Covid-19 Symptoms in Long-Term Care

Multi-Variant Covid-19 Vaccine in the Works

SARS-CoV-2 and cell

A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon. . . . → Read More: Multi-Variant Covid-19 Vaccine in the Works

Universities Form Joint Engineering Patent Pool

U.S. Patent and Trademark Office

A group of 15 American universities are putting part of their engineering patents into a common licensing pool for commercial development. . . . → Read More: Universities Form Joint Engineering Patent Pool

Digital Therapeutics Designed for Cancer/Covid-19 Stress

Man with depression

A digital health company is partnering with cancer advocacy organizations to provide electronic therapies to help patients deal with stresses from Covid-19. . . . → Read More: Digital Therapeutics Designed for Cancer/Covid-19 Stress

CureVac, Bayer Partner on Covid-19 Vaccine Supply

Syringe in hand

Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine. . . . → Read More: CureVac, Bayer Partner on Covid-19 Vaccine Supply

AI, Discovery Companies Partner on Neuro Imaging Drugs

Brain circuits

A company discovering drugs for neurodegenerative diseases and a scientific artificial intelligence provider are partnering on image tracers for brain disorders. . . . → Read More: AI, Discovery Companies Partner on Neuro Imaging Drugs

Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant

Robin Shattock

A biotechnology company and university infectious disease lab are developing a Covid-19 vaccine given as a solid dose implant under the skin. . . . → Read More: Univ. Lab, Biotech Partner on Covid-19 Vaccine Implant

Large Trial Testing Covid-19 Antibody Therapies

Global Covid-19

A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections. . . . → Read More: Large Trial Testing Covid-19 Antibody Therapies

Fitness, Phone Data Captured for Heart Health Project

Heartbeat graphic

A digital health company is partnering with a cardiologist group to capture data from smartphones and wearable devices to provide users personalized heart health information. . . . → Read More: Fitness, Phone Data Captured for Heart Health Project

Financial Asset Managers Supporting Net Zero Emissions

Wind farm

Thirty asset managers, directing investments worth some $9 trillion, agreed to encourage their clients to achieve global net zero greenhouse gas emission goals. . . . → Read More: Financial Asset Managers Supporting Net Zero Emissions